Comparative in vitro activity of oritavancin against Staphylococcus aureus strains that are resistant, intermediate or heteroresistant to vancomycin

被引：29
|
作者：
Arhin, Francis F. [1 ]
Sarmiento, Ingrid [1 ]
Parr, Thomas R., Jr. [1 ]
Moeck, Gregory [1 ]
机构：
[1] Med Co, St Laurent, PQ, Canada
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2009年 / 64卷 / 04期
关键词：
glycopeptide non-susceptible; MICs; MBCs;
D O I：
10.1093/jac/dkp286
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：868 / 870
页数：3
相关论文
共 50 条
  • [1] Evaluation of Ceftaroline Activity against Heteroresistant Vancomycin-Intermediate Staphylococcus aureus and Vancomycin-Intermediate Methicillin-Resistant S-aureus Strains in an In Vitro Pharmacokinetic/Pharmacodynamic Model: Exploring the "Seesaw Effect"
    Werth, Brian J.
    Steed, Molly E.
    Kaatz, Glenn W.
    Rybak, Michael J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (06) : 2664 - 2668
  • [2] Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus among Methicillin-Resistant Staphylococcus aureus
    Chaudhary, Bajarangi Lal
    Bisht, Dakshina
    Faujdar, Sameer
    ASIAN JOURNAL OF PHARMACEUTICAL RESEARCH AND HEALTH CARE, 2022, 14 (01) : 16 - 20
  • [3] Comparative In Vitro Activities of Oritavancin, Dalbavancin, and Vancomycin against Methicillin-Resistant Staphylococcus aureus Isolates in a Nondividing State
    Belley, Adam
    Seguin, David Lalonde
    Arhin, Francis
    Moeck, Greg
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (07) : 4342 - 4345
  • [4] Detection of heteroresistant vancomycin intermediate Staphylococcus aureus in bloodstream infection
    Harigaya, Y.
    Huang, V.
    Mylotte, J.
    Lesse, A.
    Tsuji, B.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S63 - S63
  • [5] Comparative in vitro activity of telavancin, vancomycin and linezolid against heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA)
    Leonard, Steven N.
    Szeto, Yong G.
    Zolotarev, Maria
    Grigoryan, Ilona V.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 37 (06) : 558 - 561
  • [6] Oritavancin retains bactericidal activity in vitro against standard and high inocula of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)
    Arhin, Francis F.
    Sarmiento, Ingrid
    Moeck, Gregory
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 41 (04) : 397 - 398
  • [7] In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus
    Fritsche, Thomas R.
    Rhomberg, Paul R.
    Sader, Hello S.
    Jones, Ronald N.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2008, 60 (04) : 399 - 403
  • [8] Effects of Linezolid on Suppressing Heteroresistant Vancomycin Subpopulations among Heteroresistant Vancomycin Intermediate Staphylococcus aureus (hVISA)
    Alshami, Issam
    Alharbi, Ahmed Eid
    Abdel-Aziz, Nada Abdelmohsen
    Ibrahim, Kawther Mohammed
    Eltahlawi, Rehab Abdallah
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2014, 8 : 215 - 220
  • [9] Novel Observations in 11 Heteroresistant Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Strains from South India
    Bakthavatchalam, Yamuna Devi
    Veeraraghavan, Balaji
    Peter, John Victor
    Rajinikanth, Janakiraman
    Inbanathan, Francis Yesurajan
    Ragupathi, Naveen Kumar Devanga
    Sekar, Suresh Kumar Rajamani
    GENOME ANNOUNCEMENTS, 2016, 4 (06)
  • [10] Comparative in vitro activity of oritavancin and other agents against methicillin-susceptible and methicillin-resistant Staphylococcus aureus
    Sweeney, Debora
    Shinabarger, Dean L.
    Arhin, Francis F.
    Belley, Adam
    Moeck, Greg
    Pillar, Chris M.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2017, 87 (02) : 121 - 128
12345